n-acetylneuraminoyllactose has been researched along with amyloid beta-peptides in 1 studies
| Studies (n-acetylneuraminoyllactose) | Trials (n-acetylneuraminoyllactose) | Recent Studies (post-2010) (n-acetylneuraminoyllactose) | Studies (amyloid beta-peptides) | Trials (amyloid beta-peptides) | Recent Studies (post-2010) (amyloid beta-peptides) |
|---|---|---|---|---|---|
| 56 | 2 | 43 | 3,257 | 48 | 1,626 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, A; Hayashi, YK; Malicdan, MC; Mine, T; Nishino, I; Noguchi, S; Nonaka, I; Yamamoto, T; Yonekawa, T | 1 |
1 other study(ies) available for n-acetylneuraminoyllactose and amyloid beta-peptides
| Article | Year |
|---|---|
Sialyllactose ameliorates myopathic phenotypes in symptomatic GNE myopathy model mice.
Topics: Aging; Amyloid beta-Peptides; Animals; Body Weight; Cells, Cultured; Creatine Kinase; Disease Models, Animal; Distal Myopathies; Enzyme-Linked Immunosorbent Assay; Hexosamines; Lactose; Mice; Muscle Contraction; Muscle, Skeletal; Mutation; Myoblasts; N-Acetylneuraminic Acid; Peptide Fragments; Phenotype | 2014 |